"Somos una institución comprometida con la salud de las personas, con una cultura de servicio que nos impulsa a poner al paciente en el centro de nuestras labores diarias, y cuyo trabajo está basado en estándares internacionales de seguridad y calidad, razón por la cual, somos reconocidos como la primera clínica en el Perú en obtener la más importante acreditación internacional, Joint Commission International. Contamos con una experiencia de más de 90 años, respaldada por un distinguido cuerpo médico y un selecto grupo de profesionales y técnicos en salud que, de la mano de la tecnología médica más avanzada y una moderna infraestructura, ofrecemos servicios de la más alta calidad, confiables y con la mayor calidez."

During the past decade, Clinica Anglo Americana conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Anglo Americana" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Celldex Therapeutics" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Anglo Americana" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Anglo Americana" are "Breast Cancer" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Asthma" (1 trials), "Complex Partial Seizure Disorder" (1 trials) and "Coronary Artery Disease (CAD)" (1 trials). Many other conditions were trialed in "Clinica Anglo Americana" in a lesser frequency.

Most popular intervention types in "Clinica Anglo Americana" are "Drug" (15 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials), "Ocrelizumab" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Anglo Americana" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica Anglo Americana". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Clinica Anglo Americana, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Anglo Americana, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".